CureSearch

Karma was born a sassy, fierce and bright child. Independent and inquisitive, she was determined to get the ultimate “why” of everything

Collaborative forum will provide academic pediatric oncology leaders with early industry insights to accelerate the development of new pediatric cancer treatments Bethesda, MD – March 28, 2019 – CureSearch for Children’s Cancer announces its inaugural IMPACT Series Forum, a closed-door session that will provide first-of-its-kind insight for leading academics into pharma’s early development pipeline. The inaugural forum will take place on March 28 in Atlanta, GA where Industry leader AstraZeneca and Acerta Pharma, AstraZeneca’s Hematology development arm, will meet with a select group of global academic and research experts in an opportunity to gain critical insights into their targets and mechanisms that are currently being developed for cancer, allowing earlier consideration for pediatric activity for therapeutics that may be entering clinical trials in the next three to five years or already in the clinic for adult cancers. “Research into pediatric cancers brings its own set of challenges and, with blood cancers among the most common in children, AstraZeneca and Acerta are proud to be working with CureSearch on the IMPACT Series,” stated Davy Chiodin, Vice President, Regulatory Science at Acerta Pharma. CureSearch Board Chairman Stuart Siegel, M. D, added, “We’re energized by the support of industry leaders like AstraZeneca and Acerta Pharma and the participation of global pediatric oncology leaders in our inaugural IMPACT Series Forum.

When Marianne learned about CureSearch’s history and mission that day, she was determined to join our efforts to save children, adolescents and young adults NOW and enable them to live long, healthy lives. This year, Marianne is trading in her hiking boots for running shoes as a member of our CureSearch Challenge team at Grandma’s Marathon. I am thrilled to run to raise funds for this organization that is helping to find cures and safer treatments for children’s cancer,” Marianne shared. Marianne is part of our team of inspiring CureSearch Challenge runners and walkers throughout the country who are dedicated to raising funds to cure children’s cancer.

Our daughter CC was normally a bubbly, vivacious child, but when she was diagnosed with B Cell Acute Lymphoblastic Leukemia (ALL) in October 2016, she was so sick that she made no effort to even leave her hospital bed. I wish the general public understood that it is not as rare as they think it is; that treatment is longer and harsher than they think it is; and that childhood cancer survivors often experience negative effects from the treatment later in life. CC, her big sister Reagan, our friends, family and community participate in our local CureSearch Walk with our team, Super CC. CureSearch shares our passion for funding more research to cure childhood cancer, and relentlessly pursuing better, less toxic treatments for our precious children, and they give families a voice to share our stories and advocate on behalf of our children so we can make a difference in the future of childhood cancer.